ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT00120523

Public ClinicalTrials.gov record NCT00120523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis

Study identification

NCT ID
NCT00120523
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDA Pharma GmbH & Co. KG
Industry
Enrollment
2,418 participants

Conditions and interventions

Interventions

  • Pimecrolimus Drug
  • Topical corticosteroids Drug

Drug

Eligibility (public fields only)

Age range
3 Months to 12 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2004
Primary completion
Sep 30, 2010
Completion
Sep 30, 2010
Last update posted
Feb 10, 2022

2004 – 2010

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Cholla Pediatrics Tucson Arizona 85741
Arkansas Pediatric Clinic Little Rock Arkansas 72205
Little Rock Allergy & Asthma Clinic Little Rock Arkansas 72205
9540 Artesia Blvd., Suite #1 Bellflower California 90706
Pediatric Care Medical Group, Inc. Huntington Beach California 92647
Longmont Clinical Research Longmont Colorado 80501
Children's Skin Center Miami Florida 33155
Pediatric Research Center of South Florida Palm Beach Gardens Florida 33458
AeroAllergy Research Laboratories of Savanah, Inc. Savannah Georgia 31406
The Pediatric Center Stone Mountain Georgia 30083
Wayne State University Dermatology Detroit Michigan 48201
Michigan State University - Kalamazoo Center for Med Studies Kalamazoo Michigan 49008
Respiratory Medicine Research Institute of Michigan Ypsilanti Michigan 48197
SMDC Health System Duluth Minnesota 55805
Dermatology Center for Children Minneapolis Minnesota 55404
University of Minnesota - Dept. of Dermatology Minneapolis Minnesota 55455
Radiant Research Bridgeton Missouri 63044
Dermatology Associates of Rochester, P.C. Rochester New York 14623
Capitol Pediatrics & Adolescent Center Raleigh North Carolina 27609
Dermatology Research Associates Cincinnati Ohio 245230
Ohio Pediatrics, Inc. Huber Heights Ohio 45424
The Portland Clinic Beaverton Oregon 97006
Calcagno Research and Development Gresham Oregon 97030
Allergy & Asthma Consultants, LLP Charleston South Carolina 29414
Allergic Disease and Asthma Center Greenville South Carolina 29607
University of Tennessee - Dept. of Pediatrics Memphis Tennessee 38105
Suzanne Bruce& Associates, PA Houston Texas 77056
Grand Parkway Pediatrics Sugar Land Texas 77479
Virginia Commonwealth University Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00120523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2022 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00120523 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →